[HTML] nature.comFull View

[HTML][HTML] The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes

M Xu, J Tan, W Dong, B Zou, X Teng, L Zhu… - Nature …, 2022 - nature.com
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …
被引用次数：33 相关文章

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.

M Xu, J Tan, W Dong, B Zou, X Teng, L Zhu… - Nature …, 2022 - europepmc.org
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.

M Xu, J Tan, W Dong, B Zou, X Teng… - Nature …, 2022 - search.ebscohost.com
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes

M Xu, J Tan, W Dong, B Zou, X Teng… - Nature …, 2022 - econpapers.repec.org
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes

M Xu, J Tan, W Dong, B Zou, X Teng… - Nature …, 2022 - ui.adsabs.harvard.edu
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes

M Xu, J Tan, W Dong, B Zou, X Teng… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …
[HTML] nih.gov

[HTML][HTML] The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes

M Xu, J Tan, W Dong, B Zou, X Teng, L Zhu… - Nature …, 2022 - ncbi.nlm.nih.gov
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes

M Xu, J Tan, W Dong, B Zou, X Teng, L Zhu… - Nature …, 2022 - ideas.repec.org
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …

The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.

M Xu, J Tan, W Dong, B Zou, X Teng, L Zhu… - Nature …, 2022 - europepmc.org
Systemic metabolic syndrome significantly increases the risk of morbidity and mortality in
patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis …